PubMed:27097659
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-77 | Sentence | denotes | Identifying immune mechanisms mediating the hypertension during preeclampsia. |
| T2 | 78-242 | Sentence | denotes | Preeclampsia (PE) is a pregnancy-associated disorder that affects 5-8% of pregnancies and is a major cause of maternal, fetal, and neonatal morbidity and mortality. |
| T3 | 243-442 | Sentence | denotes | Hallmark characteristics of PE are new onset hypertension after 20 wk gestation with or without proteinuria, chronic immune activation, fetal growth restriction, and maternal endothelial dysfunction. |
| T4 | 443-543 | Sentence | denotes | However, the pathophysiological mechanisms that lead to the development of PE are poorly understood. |
| T5 | 544-757 | Sentence | denotes | Recent data from studies of both clinical and animal models demonstrate an imbalance in the subpopulations of CD4+ T cells and a role for these cells as mediators of inflammation and hypertension during pregnancy. |
| T6 | 758-945 | Sentence | denotes | Specifically, it has been proposed that the imbalance between two CD4+ T cell subtypes, regulatory T cells (Tregs) and T-helper 17 cells (Th17s), is involved in the pathophysiology of PE. |
| T7 | 946-1133 | Sentence | denotes | Studies from our laboratory highlighting how this imbalance contributes to vasoactive factors, endothelial dysfunction, and hypertension during pregnancy will be discussed in this review. |
| T8 | 1134-1309 | Sentence | denotes | Therefore, the purpose of this review is to highlight hypertensive mechanisms stimulated by inflammatory factors in response to placental ischemia, thereby elucidating a role. |
| T1 | 0-77 | Sentence | denotes | Identifying immune mechanisms mediating the hypertension during preeclampsia. |
| T2 | 78-242 | Sentence | denotes | Preeclampsia (PE) is a pregnancy-associated disorder that affects 5-8% of pregnancies and is a major cause of maternal, fetal, and neonatal morbidity and mortality. |
| T3 | 243-442 | Sentence | denotes | Hallmark characteristics of PE are new onset hypertension after 20 wk gestation with or without proteinuria, chronic immune activation, fetal growth restriction, and maternal endothelial dysfunction. |
| T4 | 443-543 | Sentence | denotes | However, the pathophysiological mechanisms that lead to the development of PE are poorly understood. |
| T5 | 544-757 | Sentence | denotes | Recent data from studies of both clinical and animal models demonstrate an imbalance in the subpopulations of CD4+ T cells and a role for these cells as mediators of inflammation and hypertension during pregnancy. |
| T6 | 758-945 | Sentence | denotes | Specifically, it has been proposed that the imbalance between two CD4+ T cell subtypes, regulatory T cells (Tregs) and T-helper 17 cells (Th17s), is involved in the pathophysiology of PE. |
| T7 | 946-1133 | Sentence | denotes | Studies from our laboratory highlighting how this imbalance contributes to vasoactive factors, endothelial dysfunction, and hypertension during pregnancy will be discussed in this review. |
| T8 | 1134-1309 | Sentence | denotes | Therefore, the purpose of this review is to highlight hypertensive mechanisms stimulated by inflammatory factors in response to placental ischemia, thereby elucidating a role. |
Preeclampsia
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-Preeclampsia-B_T1 | 64-76 | ORPHA:275555 | denotes | preeclampsia |
| PD-Preeclampsia-B_T2 | 78-90 | ORPHA:275555 | denotes | Preeclampsia |
Preeclampsia-compare
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-Preeclampsia-B_T1 | 64-76 | ORPHA:275555 | denotes | preeclampsia |
| PD-Preeclampsia-B_T2 | 78-90 | ORPHA:275555 | denotes | Preeclampsia |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-77 | Sentence | denotes | Identifying immune mechanisms mediating the hypertension during preeclampsia. |
| TextSentencer_T2 | 78-242 | Sentence | denotes | Preeclampsia (PE) is a pregnancy-associated disorder that affects 5-8% of pregnancies and is a major cause of maternal, fetal, and neonatal morbidity and mortality. |
| TextSentencer_T3 | 243-442 | Sentence | denotes | Hallmark characteristics of PE are new onset hypertension after 20 wk gestation with or without proteinuria, chronic immune activation, fetal growth restriction, and maternal endothelial dysfunction. |
| TextSentencer_T4 | 443-543 | Sentence | denotes | However, the pathophysiological mechanisms that lead to the development of PE are poorly understood. |
| TextSentencer_T5 | 544-757 | Sentence | denotes | Recent data from studies of both clinical and animal models demonstrate an imbalance in the subpopulations of CD4+ T cells and a role for these cells as mediators of inflammation and hypertension during pregnancy. |
| TextSentencer_T6 | 758-945 | Sentence | denotes | Specifically, it has been proposed that the imbalance between two CD4+ T cell subtypes, regulatory T cells (Tregs) and T-helper 17 cells (Th17s), is involved in the pathophysiology of PE. |
| TextSentencer_T7 | 946-1133 | Sentence | denotes | Studies from our laboratory highlighting how this imbalance contributes to vasoactive factors, endothelial dysfunction, and hypertension during pregnancy will be discussed in this review. |
| TextSentencer_T8 | 1134-1309 | Sentence | denotes | Therefore, the purpose of this review is to highlight hypertensive mechanisms stimulated by inflammatory factors in response to placental ischemia, thereby elucidating a role. |
| T1 | 0-77 | Sentence | denotes | Identifying immune mechanisms mediating the hypertension during preeclampsia. |
| T2 | 78-242 | Sentence | denotes | Preeclampsia (PE) is a pregnancy-associated disorder that affects 5-8% of pregnancies and is a major cause of maternal, fetal, and neonatal morbidity and mortality. |
| T3 | 243-442 | Sentence | denotes | Hallmark characteristics of PE are new onset hypertension after 20 wk gestation with or without proteinuria, chronic immune activation, fetal growth restriction, and maternal endothelial dysfunction. |
| T4 | 443-543 | Sentence | denotes | However, the pathophysiological mechanisms that lead to the development of PE are poorly understood. |
| T5 | 544-757 | Sentence | denotes | Recent data from studies of both clinical and animal models demonstrate an imbalance in the subpopulations of CD4+ T cells and a role for these cells as mediators of inflammation and hypertension during pregnancy. |
| T6 | 758-945 | Sentence | denotes | Specifically, it has been proposed that the imbalance between two CD4+ T cell subtypes, regulatory T cells (Tregs) and T-helper 17 cells (Th17s), is involved in the pathophysiology of PE. |
| T7 | 946-1133 | Sentence | denotes | Studies from our laboratory highlighting how this imbalance contributes to vasoactive factors, endothelial dysfunction, and hypertension during pregnancy will be discussed in this review. |
| T8 | 1134-1309 | Sentence | denotes | Therefore, the purpose of this review is to highlight hypertensive mechanisms stimulated by inflammatory factors in response to placental ischemia, thereby elucidating a role. |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 1262-1271 | http://purl.obolibrary.org/obo/UBERON_0001987 | denotes | placental |